Author:
Nebesio Todd D.,Renbarger Jamie L.,Nabhan Zeina M.,Ross Sydney E.,Slaven James E.,Li Lang,Walvoord Emily C.,Eugster Erica A.
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:4133–60.
2. Joint LWPES/ESPE CAH Working Group. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab. 2002;87:4048–53.
3. Rivkees SA, Crawford JD. Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth. Pediatrics. 2000;106:767–73.
4. Huseman CA, Varma MM, Blizzard RM, Johnson A. Treatment of congenital adrenal virilizing adrenal hyperplasia with single and multiple daily doses of prednisone. J Pediatr. 1977;90:538–42.
5. Haas DM, Lehmann AS, Skaar T, Philips S, McCormick CL, Beagle K, et al. The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use. Am J Obstet Gynecol. 2012;206:447. e17–24.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献